Screening for Gonococcal and Chlamydial Infections in the Third Trimester


      A retrospective study was conducted at our institution of all patients who delivered between May 2016 and April 2017. A change of practice had been instituted, which involved obstetricians testing for Neisseria gonorrhoeae and Chlamydia trachomatis universally in the first and third trimesters. Medical records were reviewed for N. gonorrhoeae and C. trachomatis results and for risk factors traditionally associated with sexually transmitted infections (STIs). A substantial proportion of patients (10.7%) had not undergone screening during pregnancy. We also identified third-trimester cases of infection in asymptomatic patients who had no traditional risk factors STI acquisition, which raised the question of optimal timing for STI screening during pregnancy.


      Une étude rétrospective a été menée dans notre établissement auprès de toutes les patientes ayant accouché entre mai 2016 et avril 2017. Un changement de pratique a été instauré, lequel impliquait pour les obstétriciens d’effectuer un dépistage systématique de Neisseria gonorrhoeae et de Chlamydia trachomatis aux premier et troisième trimestres. Les dossiers médicaux ont été examinés pour recenser les résultats de dépistage de N. gonorrhoeae et de C. trachomatis et repérer les facteurs de risque traditionnellement associés aux infections transmissibles sexuellement (ITS). Une importante proportion de patientes (10,7 %) n’avaient pas subi de dépistage pendant la grossesse. Nous avons également noté des cas d’infection au troisième trimestre chez des patientes asymptomatiques n’ayant pas les facteurs de risque classiques pour contracter une ITS, ce qui a soulevé la question du moment optimal pour le dépistage des ITS pendant la grossesse.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Moore D.
        • MacDonald N.
        Preventing ophthalmia neonatorum.
        Can J Infect Dis Med Microbiol. 2015; 26: 122-125
        • Mulholland C.
        • Gardiner J.
        Ophthalmia neonatorum prophylaxis.
        Can J Ophthalmol. 2015; 50: 328-329
        • Ivensky V.
        • Mandel R.
        • Boulay A.
        • et al.
        Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: a retrospective cohort study.
        Can Commun Dis Rep. 2021; 47: 209
        • Poliquin V.
        • Wylie J.
        • Cole R.
        • et al.
        Preparedness for implementing change in neonatal ocular prophylaxis policies.
        J Obstet Gynaecol Can. 2016; 38: 7-8
        • Vainder M.
        • Kives S.
        • Yudin M.H.
        Screening for gonorrhea and chlamydia in pregnancy: room for improvement.
        J Obstet Gynaecol Can. 2019; 41: 1289-1294
      1. Ontario Ministry of Health and Long Term Care. Ophthalmia neonatorum fact sheet. 2019. Available at: Accessed on June 5, 2022.

        • Canadian Paediatric Society
        Neonatal ocular prophylaxis: shortage of erythromycin ophthalmic ointment for use in newborns.
        (Available at:) (Accessed on September 29, 2021)
        • Trivedi S.
        • Williams C.
        • Torrone E.
        • et al.
        National trends and reported risk factors among pregnant women with syphilis in the United States, 2012-2016.
        Obstet Gynecol. 2019; 133: 27-32
        • Bushman E.T.
        • Subramani L.
        • Sanjanwala A.
        • et al.
        Pragmatic experience with risk-based versus universal hepatitis c screening in pregnancy: detection of infection and postpartum linkage to care.
        Am J Perinatol. 2021; 38: 1109-1116
        • Tyker A.
        • Pudwell J.
        • Schneiderman M.
        • et al.
        Prevalence of chlamydia and gonorrhea among pregnant adolescents screened in the third trimester using a urine PCR test: a retrospective review.
        J Obstet Gynaecol Can. 2021; 43: 1069-1075